BTIG Reiterates Buy on BrightSpring Health, Maintains $55 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.0%

Neg 0% Neu 90% Pos 0%

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $55 price target.

Comments

No comments yet. Be the first!